The Scientist

» ENCODE, microbiology and disease/medicine

Most Recent

image: Messing with HIV

Messing with HIV

By | June 1, 2012

Sangamo Biosciences is putting a different spin on gene therapy. 

0 Comments

image: From Bones to Brains

From Bones to Brains

By | June 1, 2012

With the help of a mother, one researcher uncovered a common link between autism and a devastating bone disease.

2 Comments

image: Microbiology Goes High-Tech

Microbiology Goes High-Tech

By | June 1, 2012

Out with toothpicks and pipettors; in with automation.

0 Comments

image: Regulations for Biosimilars

Regulations for Biosimilars

By | June 1, 2012

As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?

2 Comments

image: Targeting DNA

Targeting DNA

By | June 1, 2012

After 20 years of high-profile failure, gene therapy is finally well on its way to clinical approval.

13 Comments

The Blood Exchange, Circa 1930

By | June 1, 2012

Early 20th century cross circulation experiments on dogs paved the way for milestones in human cardiac surgery.

1 Comment

image: Underground Supermodels

Underground Supermodels

By | June 1, 2012

What can a twentysomething naked mole-rat tell us about fighting pain, cancer, and aging?

12 Comments

image: Active Brains Help Heal Paralysis

Active Brains Help Heal Paralysis

By | May 31, 2012

Engaging the brain with cognitive tasks helps paralyzed rats walk again.

4 Comments

image: Famed Geneticist Dies

Famed Geneticist Dies

By | May 31, 2012

David Rimoin, a medical geneticist and the founding president of the American College of Medical Genetics and Genomics, passes away at age 75.

0 Comments

image: Breast Milk Antibodies Fight HIV

Breast Milk Antibodies Fight HIV

By | May 30, 2012

The anti-HIV antibodies from mothers carrying HIV could be used to help develop a vaccine.

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham